Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-09-08
2000-05-23
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514652, 514912, A61K 31135
Patent
active
060666757
ABSTRACT:
Methods for the stimulation of growth factor expression and for treatment of retinal diseases with alpha- and beta-adrenergic agonists are disclosed.
REFERENCES:
patent: 3906949 (1975-09-01), Holland
patent: 4007268 (1977-02-01), Voorhees
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
patent: 5019369 (1991-05-01), Presant et al.
patent: 5667968 (1997-09-01), Lavail
Faktorovich et al., Nature, 347:83-86, Sep. 6, 1990.
Wen et al., J. Neurosci., 15:11:7377-7385, Nov. 1995.
Baird, A., "Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors,"Curr. Opin, Neurobiol. 4:78-86 1994).
Bittiger, H. et al., "Are only .alpha..sub.2 -adrenergic receptors present in bovine retina?,"Nature 287:645-647 (1980).
Bowman, L.H. et al., "Multiphe ribosomal RNA cleavage pathways in mammalian cells," Nucl. Acids Res. 9(19) :4951-4966 (1981).
Burney, I.A. et al., "Effect of Vasoactive Drugs on Tumor Blood Flow as Determined by .sup.2 H Nuclear Magnetic Resonance Spectroscopy,"Acta Oncologica 34(3) :367-371 (1995).
Bush, R.A. et al., "The Effect of Unilateral Optic Nerve Section on Retinal Light Damage in Rats," Exp. Eye Res. 52 :139-153 (1991).
Bylund, D.B., "Subtypes of .alpha..sub.1 -and .alpha..sub.2 -adrenergic receptors," FASEB J. 6:832-839 (1992).
Elena, P-P. et al., "Autoradiographic Localization of Beta-Adrenergic Receptors in Rabbit Eye," Invest. Opthalmology and Vis. Sci. 28 (8) : 1436-1441 (1987).
Elena, P-P et al., "Beta Adrenergic Binding Sites in the Human Eye: An Autoradiographic Study, " J. Ocu. Pharm. 6 (2) :143-149 (1990).
Ferrari-Dileo, G., "Beta.sub.1 Beta.sub.2 Adrenergic Binding Sites in Bovine Retina and Retinal Blood Vessels," Invest. Opthalmology and Vis. Sci. 29 (5) :695-699 (1988).
Follesa, P. et al., "Regulation of Basic Fibroblast Growth Factor and Nerve Growth Factor mRNA by .beta.-Adrenergic Receptor Activation anf Adrenal Steroids in Rat Central Nervous System," Mol. Pharm. 43:132-138 (1993).
Gao, H. etal., "Basic Fibroblast Growth Factor in Retinal Development: Differential Levels of bFGF Expression and Content in Normal and Retinal Degeneration (rd) Mutant Mice,"Devel. Biol. 169:168-184 (1995).
Gao, H. et al., "Basic Fibroblast Growth Factor: Increased Gene Expression in Inherited and Light-Induced Photoreceptor Degeneration," Exp. Eye Res. 62:181-189 (1996).
Jakobs, K.H., "Inhibition of adenylate cyclase by hormones and neurotransmitters," Mol. Cell. Endocrin.16:147-156 (1979).
Kostyk, S.K,. et al., "Optic Nerve Injury Alters Basic Fibroblast Growth Factor Localization in the Retina and Optic Tract," J. Neurosci. 14 (3):1441-1229 (1994).
LaVail, M.M. et al., "Influence of Eye Pigmentation and Light Deprivation on Inherited Retinal Dystrophy in the Rat," Exp. Eye Res. 21:167-192 (1975).
Osborne, N.N., "Binding of (--) [.sup.3 H] Noradrenaline to Bovine Membrane of the Retina. Evidence for the Existence of .alpha..sub.2 -Receptors," Vision Res. 22:1401-1407 (1982).
Osborne, N.N., "Inhibition of cAMP prodution by .alpha..sub.2 -adrenoceptor stimulation in rabbit retina," Brain Res. 553:84-88 (1991).
Park, C.M. et al., "Growth Factor-Induced Retinal Regeneration in Vivo, " Int'Rev. Cytol. 146:49-74 (1993).
Shimasaki, S. et al., "Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA," Biochem. Biophys. Res. Commun. 157(1) :256-263 (1988).
Stachowiak, M.K. et al., "Regulation of bFGF Gene Expression and Subcellular Distribution of bFGF Protein in Adrenal Medullary Cells," J. Cell Biol. 127(1) ;203-223 (1994).
Steinberg, R.H., "Survival factors in retinal degenerations,"Curr. Opin. Neuro. 4:515-5224 (1994).
Szoka, F. et al., "Comparative properties and methods of preparation of lipid vesicles (lipsomes) ,"Ann. Rev. Biophys. Bioeng. 9:467-508 (1980).
Wagner, J.A. "The Fibroblast Growth Factors: An Emerging Family of Neural Growth Factors," Curr. Topics Microbiol. Immunol. 165:95-118 (1991).
Wen, R. et al., "Injury-Induced Upregulation of bFGF and CNTF mRNAS in the Rat Retina,"J. Neurosci. 15 (11) :7377-7385 (1995).
Wikberg-Matsson, A. et al., "Characterization of .alpha..sub.2A -Adrenoceptor Subtypes in the Procine Eye: Identification of .alpha..sub.2c -Adrenoceptors in the Retina," Exp. Eye Res. 63:57-66 (1996).
Zarbin, M.A. et al., "Autoradiographic Localization of High Affinity GABA, Benzodiazepine, Dopaminergic, Adrenergic and Muscarinic Cholinergic Receptors in the Rat, Monkey and Human Retina," Brain Res. 374:75-92 (1986).
LaVail Matthew M.
Steinberg, deceased Roy H.
Wen Rong
Fay Zohreh
The Regents of the University of California
LandOfFree
Method for treatment of retinal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of retinal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of retinal diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837495